

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-12 production (GO:0032695) | 5.08324705 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.87322950 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.87322950 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.70366409 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 4.35578966 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.35578966 |
| 7 | regulation of mast cell degranulation (GO:0043304) | 4.34084309 |
| 8 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.25482929 |
| 9 | immunoglobulin mediated immune response (GO:0016064) | 4.21837841 |
| 10 | detection of molecule of bacterial origin (GO:0032490) | 4.07093266 |
| 11 | detection of other organism (GO:0098543) | 4.06452901 |
| 12 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.01755234 |
| 13 | regulation of mast cell activation involved in immune response (GO:0033006) | 4.01199104 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.93237825 |
| 15 | negative regulation of cell killing (GO:0031342) | 3.93237825 |
| 16 | microglial cell activation (GO:0001774) | 3.90608752 |
| 17 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.84395011 |
| 18 | regulation of leukocyte degranulation (GO:0043300) | 3.81730964 |
| 19 | regulation of mast cell activation (GO:0033003) | 3.76604042 |
| 20 | neutrophil activation involved in immune response (GO:0002283) | 3.75319598 |
| 21 | detection of external biotic stimulus (GO:0098581) | 3.75284587 |
| 22 | detection of bacterium (GO:0016045) | 3.72283183 |
| 23 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.70578830 |
| 24 | macrophage activation (GO:0042116) | 3.69898880 |
| 25 | granulocyte activation (GO:0036230) | 3.66225296 |
| 26 | neutrophil activation (GO:0042119) | 3.64316311 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.61587756 |
| 28 | Golgi transport vesicle coating (GO:0048200) | 3.57209161 |
| 29 | COPI coating of Golgi vesicle (GO:0048205) | 3.57209161 |
| 30 | aromatic amino acid family catabolic process (GO:0009074) | 3.49127249 |
| 31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.48883115 |
| 32 | response to host immune response (GO:0052572) | 3.48883115 |
| 33 | myeloid cell activation involved in immune response (GO:0002275) | 3.46290686 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 3.44162319 |
| 35 | response to muramyl dipeptide (GO:0032495) | 3.42253876 |
| 36 | detection of biotic stimulus (GO:0009595) | 3.41761589 |
| 37 | response to lipoprotein particle (GO:0055094) | 3.40405015 |
| 38 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.40174942 |
| 39 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.40174942 |
| 40 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.40174942 |
| 41 | modulation by symbiont of host immune response (GO:0052553) | 3.40174942 |
| 42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.40174942 |
| 43 | modulation by symbiont of host defense response (GO:0052031) | 3.40174942 |
| 44 | cellular extravasation (GO:0045123) | 3.35586370 |
| 45 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.34509649 |
| 46 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.33762886 |
| 47 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.33762886 |
| 48 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.32804197 |
| 49 | regulation of regulated secretory pathway (GO:1903305) | 3.25811093 |
| 50 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.25528631 |
| 51 | protein carboxylation (GO:0018214) | 3.25528631 |
| 52 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.23458370 |
| 53 | amino sugar catabolic process (GO:0046348) | 3.23340383 |
| 54 | glycosphingolipid catabolic process (GO:0046479) | 3.21080424 |
| 55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.20903150 |
| 56 | amyloid precursor protein catabolic process (GO:0042987) | 3.20872526 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.18087962 |
| 58 | defense response to protozoan (GO:0042832) | 3.16117859 |
| 59 | complement activation, alternative pathway (GO:0006957) | 3.11332631 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.10911087 |
| 61 | T-helper 1 type immune response (GO:0042088) | 3.09819164 |
| 62 | respiratory burst (GO:0045730) | 3.09200929 |
| 63 | positive regulation of antigen processing and presentation (GO:0002579) | 3.08800182 |
| 64 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.08046273 |
| 65 | fatty acid elongation (GO:0030497) | 3.07465268 |
| 66 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.06103943 |
| 67 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.05754537 |
| 68 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.05427688 |
| 69 | central nervous system myelination (GO:0022010) | 3.02249719 |
| 70 | axon ensheathment in central nervous system (GO:0032291) | 3.02249719 |
| 71 | response to protozoan (GO:0001562) | 3.01857734 |
| 72 | sequestering of metal ion (GO:0051238) | 3.01522064 |
| 73 | neutrophil mediated immunity (GO:0002446) | 3.01206517 |
| 74 | positive regulation of regulated secretory pathway (GO:1903307) | 3.01136208 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 3.00718458 |
| 76 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.99913422 |
| 77 | oligosaccharide catabolic process (GO:0009313) | 2.97788435 |
| 78 | response to host (GO:0075136) | 2.97068122 |
| 79 | response to host defenses (GO:0052200) | 2.97068122 |
| 80 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.97068122 |
| 81 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.95815426 |
| 82 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.95760730 |
| 83 | B cell mediated immunity (GO:0019724) | 2.94191162 |
| 84 | regulation of antigen processing and presentation (GO:0002577) | 2.93418293 |
| 85 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.93380755 |
| 86 | signal peptide processing (GO:0006465) | 2.92944985 |
| 87 | response to thyroid hormone (GO:0097066) | 2.92378672 |
| 88 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.91833182 |
| 89 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89590555 |
| 90 | macrophage activation involved in immune response (GO:0002281) | 2.88259613 |
| 91 | germinal center formation (GO:0002467) | 2.86973257 |
| 92 | glycolipid catabolic process (GO:0019377) | 2.86823614 |
| 93 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.83285811 |
| 94 | negative regulation of interleukin-17 production (GO:0032700) | 2.83260465 |
| 95 | bile acid biosynthetic process (GO:0006699) | 2.80439012 |
| 96 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.80381626 |
| 97 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.78768078 |
| 98 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.78635268 |
| 99 | N-acetylneuraminate metabolic process (GO:0006054) | 2.74976745 |
| 100 | very long-chain fatty acid metabolic process (GO:0000038) | 2.74637576 |
| 101 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.71682764 |
| 102 | phagosome maturation (GO:0090382) | 2.71012688 |
| 103 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.70940959 |
| 104 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.70461656 |
| 105 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.70103488 |
| 106 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.69775740 |
| 107 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.69060904 |
| 108 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.69060904 |
| 109 | amyloid precursor protein metabolic process (GO:0042982) | 2.68929633 |
| 110 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.66863682 |
| 111 | neutrophil chemotaxis (GO:0030593) | 2.66270323 |
| 112 | mature B cell differentiation involved in immune response (GO:0002313) | 2.65253759 |
| 113 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.65057336 |
| 114 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.64141837 |
| 115 | tyrosine metabolic process (GO:0006570) | 2.63381319 |
| 116 | regulation of hypersensitivity (GO:0002883) | 2.63178373 |
| 117 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62750477 |
| 118 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.62678546 |
| 119 | negative regulation of granulocyte differentiation (GO:0030853) | 2.62220932 |
| 120 | negative regulation of interleukin-6 production (GO:0032715) | 2.62043128 |
| 121 | myeloid leukocyte activation (GO:0002274) | 2.61846319 |
| 122 | sulfur amino acid catabolic process (GO:0000098) | 2.61708111 |
| 123 | glyoxylate metabolic process (GO:0046487) | 2.61054031 |
| 124 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.60498460 |
| 125 | leukocyte aggregation (GO:0070486) | 2.60440609 |
| 126 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.60430323 |
| 127 | positive regulation of macrophage cytokine production (GO:0060907) | 2.59901024 |
| 128 | bile acid metabolic process (GO:0008206) | 2.59776490 |
| 129 | neutrophil migration (GO:1990266) | 2.59219300 |
| 130 | myeloid leukocyte mediated immunity (GO:0002444) | 2.58583491 |
| 131 | positive regulation of leukocyte degranulation (GO:0043302) | 2.58087484 |
| 132 | cholesterol efflux (GO:0033344) | 2.57884136 |
| 133 | low-density lipoprotein particle clearance (GO:0034383) | 2.56191840 |
| 134 | high-density lipoprotein particle remodeling (GO:0034375) | 2.54525355 |
| 135 | opsonization (GO:0008228) | 2.54151959 |
| 136 | creatine metabolic process (GO:0006600) | 2.53673614 |
| 137 | endocrine pancreas development (GO:0031018) | 2.53552396 |
| 138 | reverse cholesterol transport (GO:0043691) | 2.51855951 |
| 139 | regulation of lipoprotein metabolic process (GO:0050746) | 2.51614987 |
| 140 | regulation of triglyceride catabolic process (GO:0010896) | 2.51360241 |
| 141 | positive regulation of B cell differentiation (GO:0045579) | 2.51234885 |
| 142 | phospholipid efflux (GO:0033700) | 2.50783830 |
| 143 | response to methylmercury (GO:0051597) | 2.49944317 |
| 144 | drug transmembrane transport (GO:0006855) | 2.49708045 |
| 145 | regulation of cholesterol metabolic process (GO:0090181) | 2.47875873 |
| 146 | regulation of protein activation cascade (GO:2000257) | 2.45672431 |
| 147 | cysteine metabolic process (GO:0006534) | 2.44440562 |
| 148 | cofactor catabolic process (GO:0051187) | 2.44222234 |
| 149 | aldehyde catabolic process (GO:0046185) | 2.43584148 |
| 150 | glycosylceramide metabolic process (GO:0006677) | 2.41871294 |
| 151 | response to peptidoglycan (GO:0032494) | 2.40482715 |
| 152 | COPII vesicle coating (GO:0048208) | 2.38936853 |
| 153 | peptide hormone processing (GO:0016486) | 2.38322726 |
| 154 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.37913542 |
| 155 | regulation of complement activation (GO:0030449) | 2.36915948 |
| 156 | aromatic amino acid family metabolic process (GO:0009072) | 2.36453031 |
| 157 | macroautophagy (GO:0016236) | 2.36223341 |
| 158 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.35287185 |
| 159 | myelin maintenance (GO:0043217) | 2.34996486 |
| 160 | protein-lipid complex assembly (GO:0065005) | 2.34191492 |
| 161 | protein-lipid complex remodeling (GO:0034368) | 2.32695333 |
| 162 | macromolecular complex remodeling (GO:0034367) | 2.32695333 |
| 163 | plasma lipoprotein particle remodeling (GO:0034369) | 2.32695333 |
| 164 | intracellular pH reduction (GO:0051452) | 2.31969524 |
| 165 | adenosine receptor signaling pathway (GO:0001973) | 2.31876810 |
| 166 | mannose metabolic process (GO:0006013) | 2.30698007 |
| 167 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.30622839 |
| 168 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.30277193 |
| 169 | positive regulation of mast cell activation (GO:0033005) | 2.30177490 |
| 170 | ethanol oxidation (GO:0006069) | 2.29858181 |
| 171 | regulation of cholesterol esterification (GO:0010872) | 2.29266177 |
| 172 | heme transport (GO:0015886) | 2.28937272 |
| 173 | tryptophan metabolic process (GO:0006568) | 2.28522388 |
| 174 | positive regulation of steroid metabolic process (GO:0045940) | 2.28428122 |
| 175 | positive regulation of mast cell degranulation (GO:0043306) | 2.28288228 |
| 176 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.28288228 |
| 177 | reactive oxygen species biosynthetic process (GO:1903409) | 2.28068612 |
| 178 | plasma lipoprotein particle assembly (GO:0034377) | 2.27411376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.57518182 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.12967663 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.06346066 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.53650895 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.47008219 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.35683891 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.19449229 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.11286268 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 3.08510699 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02674321 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.92447268 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.92299611 |
| 13 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.86675164 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.85639677 |
| 15 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80822370 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.59737372 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.55995344 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.40194663 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.38916300 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32181665 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.27776465 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.24437088 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.02646359 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01512309 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.93794573 |
| 26 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90957814 |
| 27 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78273200 |
| 28 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77920698 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75846145 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.68828467 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.62627323 |
| 32 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.62591863 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60188381 |
| 34 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56999506 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.55047980 |
| 36 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.54365270 |
| 37 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.54148879 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54138569 |
| 39 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53038151 |
| 40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.51662976 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50329245 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.47351895 |
| 43 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45429343 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42105181 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40230474 |
| 46 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.39941792 |
| 47 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39761922 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.39690873 |
| 49 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.38501879 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.37544825 |
| 51 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37329276 |
| 52 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.36603500 |
| 53 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36576998 |
| 54 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32862028 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32530798 |
| 56 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.30658848 |
| 57 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.29273172 |
| 58 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28578206 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26431563 |
| 60 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26239334 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.25932530 |
| 62 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.23944212 |
| 63 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23075127 |
| 64 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.23055731 |
| 65 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21461412 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20245660 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.17685843 |
| 68 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.17667436 |
| 69 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16575682 |
| 70 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16404786 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16207298 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16095764 |
| 73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14422192 |
| 74 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13986239 |
| 75 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13370570 |
| 76 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.13154263 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12919585 |
| 78 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12095232 |
| 79 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11273836 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 1.11254220 |
| 81 | MAF_26560356_Chip-Seq_TH2_Human | 1.10533520 |
| 82 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.09731785 |
| 83 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08989079 |
| 84 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07835876 |
| 85 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06901524 |
| 86 | MAF_26560356_Chip-Seq_TH1_Human | 1.06277303 |
| 87 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06035360 |
| 88 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05486412 |
| 89 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03576744 |
| 90 | MYC_22102868_ChIP-Seq_BL_Human | 1.02959993 |
| 91 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02209638 |
| 92 | MYB_26560356_Chip-Seq_TH1_Human | 1.01895278 |
| 93 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.01774620 |
| 94 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00266464 |
| 95 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.98682612 |
| 96 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98660057 |
| 97 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98571643 |
| 98 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97994775 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97734342 |
| 100 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.96672717 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96319502 |
| 102 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95848901 |
| 103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95232357 |
| 104 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94150496 |
| 105 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.94044121 |
| 106 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93575476 |
| 107 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.93434918 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92861859 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91982334 |
| 110 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91098112 |
| 111 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90666452 |
| 112 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89702736 |
| 113 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89589221 |
| 114 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.88099612 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87946648 |
| 116 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87939155 |
| 117 | UTX_26944678_Chip-Seq_JUKART_Human | 0.87515934 |
| 118 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87353458 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87271434 |
| 120 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87209984 |
| 121 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.86973834 |
| 122 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86158599 |
| 123 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.84647433 |
| 124 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84047044 |
| 125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82429175 |
| 126 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.80542339 |
| 127 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79769159 |
| 128 | P68_20966046_ChIP-Seq_HELA_Human | 0.76730838 |
| 129 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.76662500 |
| 130 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.75484472 |
| 131 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.74091269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.83217027 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.62515338 |
| 3 | MP0009840_abnormal_foam_cell | 3.48766249 |
| 4 | MP0003195_calcinosis | 3.46810113 |
| 5 | MP0005365_abnormal_bile_salt | 2.98204823 |
| 6 | MP0005360_urolithiasis | 2.87950850 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.82233367 |
| 8 | MP0003303_peritoneal_inflammation | 2.56919273 |
| 9 | MP0009278_abnormal_bone_marrow | 2.55712606 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.54786191 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.47826955 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.43787467 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.43787467 |
| 14 | MP0003183_abnormal_peptide_metabolism | 2.38606169 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.37796887 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.37310958 |
| 17 | MP0000920_abnormal_myelination | 2.33803697 |
| 18 | MP0003436_decreased_susceptibility_to | 2.28995307 |
| 19 | MP0003690_abnormal_glial_cell | 2.24913884 |
| 20 | MP0001835_abnormal_antigen_presentation | 2.21679683 |
| 21 | MP0006082_CNS_inflammation | 2.19999490 |
| 22 | MP0002419_abnormal_innate_immunity | 2.11786904 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 2.05541209 |
| 24 | MP0003252_abnormal_bile_duct | 2.00706384 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.92288866 |
| 26 | MP0003724_increased_susceptibility_to | 1.86736613 |
| 27 | MP0010329_abnormal_lipoprotein_level | 1.80779432 |
| 28 | MP0000604_amyloidosis | 1.80206761 |
| 29 | MP0004043_abnormal_pH_regulation | 1.66948062 |
| 30 | MP0005025_abnormal_response_to | 1.66607780 |
| 31 | MP0005000_abnormal_immune_tolerance | 1.65259614 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.61711997 |
| 33 | MP0009785_altered_susceptibility_to | 1.61341371 |
| 34 | MP0005083_abnormal_biliary_tract | 1.59935922 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.57559740 |
| 36 | MP0002693_abnormal_pancreas_physiology | 1.53697365 |
| 37 | MP0003075_altered_response_to | 1.52494147 |
| 38 | MP0008469_abnormal_protein_level | 1.52310190 |
| 39 | MP0000609_abnormal_liver_physiology | 1.51672875 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.51093507 |
| 41 | MP0005387_immune_system_phenotype | 1.50939501 |
| 42 | MP0001790_abnormal_immune_system | 1.50939501 |
| 43 | MP0001666_abnormal_nutrient_absorption | 1.47459214 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.47057899 |
| 45 | MP0005332_abnormal_amino_acid | 1.46031688 |
| 46 | MP0002138_abnormal_hepatobiliary_system | 1.45607217 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.44162717 |
| 48 | MP0000685_abnormal_immune_system | 1.38250074 |
| 49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.36667478 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.36368381 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.35313118 |
| 52 | MP0003828_pulmonary_edema | 1.34734018 |
| 53 | MP0002723_abnormal_immune_serum | 1.34583767 |
| 54 | MP0008260_abnormal_autophagy | 1.29980981 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.29798426 |
| 56 | MP0002452_abnormal_antigen_presenting | 1.28325320 |
| 57 | MP0000013_abnormal_adipose_tissue | 1.21297843 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.19402409 |
| 59 | MP0001800_abnormal_humoral_immune | 1.17149007 |
| 60 | MP0001944_abnormal_pancreas_morphology | 1.16157312 |
| 61 | MP0002398_abnormal_bone_marrow | 1.15643389 |
| 62 | MP0005310_abnormal_salivary_gland | 1.15030801 |
| 63 | MP0001851_eye_inflammation | 1.14467657 |
| 64 | MP0005167_abnormal_blood-brain_barrier | 1.13047664 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 1.11803185 |
| 66 | MP0002420_abnormal_adaptive_immunity | 1.11445648 |
| 67 | MP0001819_abnormal_immune_cell | 1.11048305 |
| 68 | MP0002653_abnormal_ependyma_morphology | 1.10931168 |
| 69 | MP0005671_abnormal_response_to | 1.09517377 |
| 70 | MP0008004_abnormal_stomach_pH | 1.09106137 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.07998741 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 1.07491183 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 1.06565136 |
| 74 | MP0004947_skin_inflammation | 1.06033273 |
| 75 | MP0005220_abnormal_exocrine_pancreas | 1.05096069 |
| 76 | MP0003329_amyloid_beta_deposits | 1.01409282 |
| 77 | MP0003868_abnormal_feces_composition | 1.01230624 |
| 78 | MP0009764_decreased_sensitivity_to | 1.00618147 |
| 79 | MP0003186_abnormal_redox_activity | 1.00157093 |
| 80 | MP0002429_abnormal_blood_cell | 0.99650552 |
| 81 | MP0009763_increased_sensitivity_to | 0.99451472 |
| 82 | MP0005379_endocrine/exocrine_gland_phen | 0.99386382 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.96401143 |
| 84 | MP0000858_altered_metastatic_potential | 0.94369556 |
| 85 | MP0004883_abnormal_blood_vessel | 0.93525447 |
| 86 | MP0005636_abnormal_mineral_homeostasis | 0.92940285 |
| 87 | MP0000343_altered_response_to | 0.92811603 |
| 88 | MP0002722_abnormal_immune_system | 0.90989282 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.89790686 |
| 90 | MP0004130_abnormal_muscle_cell | 0.89630042 |
| 91 | MP0002132_abnormal_respiratory_system | 0.89563183 |
| 92 | MP0001756_abnormal_urination | 0.88607832 |
| 93 | MP0009642_abnormal_blood_homeostasis | 0.88600123 |
| 94 | MP0000598_abnormal_liver_morphology | 0.87224781 |
| 95 | MP0001663_abnormal_digestive_system | 0.86898860 |
| 96 | MP0003448_altered_tumor_morphology | 0.86831591 |
| 97 | MP0005408_hypopigmentation | 0.86383846 |
| 98 | MP0002998_abnormal_bone_remodeling | 0.85200694 |
| 99 | MP0002933_joint_inflammation | 0.83858036 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.83714883 |
| 101 | MP0001853_heart_inflammation | 0.83684464 |
| 102 | MP0001764_abnormal_homeostasis | 0.83526617 |
| 103 | MP0003634_abnormal_glial_cell | 0.83443221 |
| 104 | MP0003633_abnormal_nervous_system | 0.82402256 |
| 105 | MP0008874_decreased_physiological_sensi | 0.81273814 |
| 106 | MP0004510_myositis | 0.80423180 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.79492233 |
| 108 | MP0002405_respiratory_system_inflammati | 0.79284238 |
| 109 | MP0003866_abnormal_defecation | 0.78854493 |
| 110 | MP0000639_abnormal_adrenal_gland | 0.78686417 |
| 111 | MP0005166_decreased_susceptibility_to | 0.78611104 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.78510148 |
| 113 | MP0005390_skeleton_phenotype | 0.78175651 |
| 114 | MP0000716_abnormal_immune_system | 0.78002932 |
| 115 | MP0005164_abnormal_response_to | 0.77275560 |
| 116 | MP0003787_abnormal_imprinting | 0.77062377 |
| 117 | MP0001501_abnormal_sleep_pattern | 0.76713407 |
| 118 | MP0005535_abnormal_body_temperature | 0.76658537 |
| 119 | MP0006054_spinal_hemorrhage | 0.75575020 |
| 120 | MP0000003_abnormal_adipose_tissue | 0.75074968 |
| 121 | MP0005334_abnormal_fat_pad | 0.74670426 |
| 122 | MP0002064_seizures | 0.74171914 |
| 123 | MP0002971_abnormal_brown_adipose | 0.73590017 |
| 124 | MP0001661_extended_life_span | 0.73101784 |
| 125 | MP0005451_abnormal_body_composition | 0.72831834 |
| 126 | MP0003631_nervous_system_phenotype | 0.70977276 |
| 127 | MP0000015_abnormal_ear_pigmentation | 0.70151681 |
| 128 | MP0003879_abnormal_hair_cell | 0.70115714 |
| 129 | MP0000569_abnormal_digit_pigmentation | 0.68221678 |
| 130 | MP0003632_abnormal_nervous_system | 0.67755145 |
| 131 | MP0002277_abnormal_respiratory_mucosa | 0.65393330 |
| 132 | MP0005075_abnormal_melanosome_morpholog | 0.61445023 |
| 133 | MP0004742_abnormal_vestibular_system | 0.58431216 |
| 134 | MP0000681_abnormal_thyroid_gland | 0.58387987 |
| 135 | MP0005165_increased_susceptibility_to | 0.57899307 |
| 136 | MP0000249_abnormal_blood_vessel | 0.55183573 |
| 137 | MP0005647_abnormal_sex_gland | 0.54170261 |
| 138 | MP0003795_abnormal_bone_structure | 0.53023400 |
| 139 | MP0005666_abnormal_adipose_tissue | 0.52556319 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.91266550 |
| 2 | Dysostosis multiplex (HP:0000943) | 4.39585460 |
| 3 | Myositis (HP:0100614) | 4.25640084 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.25235930 |
| 5 | Stomatitis (HP:0010280) | 4.24791017 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.20365004 |
| 7 | Orchitis (HP:0100796) | 3.98225126 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.97545894 |
| 9 | Hypoglycemic coma (HP:0001325) | 3.86488658 |
| 10 | Complement deficiency (HP:0004431) | 3.82944620 |
| 11 | Mutism (HP:0002300) | 3.81858305 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 3.81460424 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 3.77467615 |
| 14 | Mucopolysacchariduria (HP:0008155) | 3.74274201 |
| 15 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.74274201 |
| 16 | Optic neuritis (HP:0100653) | 3.72328337 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.72328337 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.64766800 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.59893679 |
| 20 | Hypoglycemic seizures (HP:0002173) | 3.58863626 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.57609018 |
| 22 | Xanthomatosis (HP:0000991) | 3.56987531 |
| 23 | Obstructive lung disease (HP:0006536) | 3.56099408 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.56099408 |
| 25 | Neurofibrillary tangles (HP:0002185) | 3.55040599 |
| 26 | Intrahepatic cholestasis (HP:0001406) | 3.51119193 |
| 27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.48872207 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.45870934 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.40918882 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.40918882 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.40918882 |
| 32 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.38862568 |
| 33 | Axonal loss (HP:0003447) | 3.35584131 |
| 34 | Abnormality of macrophages (HP:0004311) | 3.30023422 |
| 35 | Glomerulonephritis (HP:0000099) | 3.27794195 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.24236530 |
| 37 | Deep venous thrombosis (HP:0002625) | 3.20882163 |
| 38 | Hyperlipoproteinemia (HP:0010980) | 3.18226086 |
| 39 | Progressive neurologic deterioration (HP:0002344) | 3.07615683 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 3.06651997 |
| 41 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.06530281 |
| 42 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.06530281 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 3.06530281 |
| 44 | Petechiae (HP:0000967) | 3.02873849 |
| 45 | Recurrent fungal infections (HP:0002841) | 3.00921479 |
| 46 | Joint hemorrhage (HP:0005261) | 2.99760230 |
| 47 | Prolonged partial thromboplastin time (HP:0003645) | 2.98934667 |
| 48 | Prolonged bleeding time (HP:0003010) | 2.89362084 |
| 49 | Abnormality of complement system (HP:0005339) | 2.87598421 |
| 50 | Symptomatic seizures (HP:0011145) | 2.86873133 |
| 51 | Ketosis (HP:0001946) | 2.78183678 |
| 52 | Retinal atrophy (HP:0001105) | 2.77654506 |
| 53 | Meningitis (HP:0001287) | 2.75442990 |
| 54 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.70075731 |
| 55 | Autoimmune thrombocytopenia (HP:0001973) | 2.68920846 |
| 56 | Ketoacidosis (HP:0001993) | 2.68634504 |
| 57 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.60268352 |
| 58 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.60268352 |
| 59 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.60150398 |
| 60 | Increased serum ferritin (HP:0003281) | 2.59470124 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.58903118 |
| 62 | Recurrent skin infections (HP:0001581) | 2.58331339 |
| 63 | Spontaneous hematomas (HP:0007420) | 2.58302534 |
| 64 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56874626 |
| 65 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56874626 |
| 66 | Neuronal loss in central nervous system (HP:0002529) | 2.56416798 |
| 67 | Diminished motivation (HP:0000745) | 2.54802759 |
| 68 | Inappropriate behavior (HP:0000719) | 2.52672058 |
| 69 | Hepatosplenomegaly (HP:0001433) | 2.51820896 |
| 70 | Agnosia (HP:0010524) | 2.48093741 |
| 71 | Cerebral inclusion bodies (HP:0100314) | 2.47500940 |
| 72 | Keratoconjunctivitis sicca (HP:0001097) | 2.46399880 |
| 73 | Encephalitis (HP:0002383) | 2.43334043 |
| 74 | Loss of speech (HP:0002371) | 2.43026468 |
| 75 | Peripheral demyelination (HP:0011096) | 2.41142183 |
| 76 | Urticaria (HP:0001025) | 2.40784545 |
| 77 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.40153403 |
| 78 | Abnormality of the periventricular white matter (HP:0002518) | 2.39302540 |
| 79 | Apathy (HP:0000741) | 2.38413162 |
| 80 | Cellulitis (HP:0100658) | 2.37700775 |
| 81 | Hemoptysis (HP:0002105) | 2.34999336 |
| 82 | Amyloidosis (HP:0011034) | 2.34590096 |
| 83 | Abnormality of iron homeostasis (HP:0011031) | 2.34398505 |
| 84 | Gingival bleeding (HP:0000225) | 2.32117786 |
| 85 | Conjugated hyperbilirubinemia (HP:0002908) | 2.32007684 |
| 86 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.31797125 |
| 87 | Late onset (HP:0003584) | 2.30021535 |
| 88 | Pulmonary infiltrates (HP:0002113) | 2.29884830 |
| 89 | Myocardial infarction (HP:0001658) | 2.29241810 |
| 90 | Keratoconjunctivitis (HP:0001096) | 2.28741990 |
| 91 | Large for gestational age (HP:0001520) | 2.26395206 |
| 92 | Thoracic kyphosis (HP:0002942) | 2.23324731 |
| 93 | Chronic otitis media (HP:0000389) | 2.21439797 |
| 94 | Fat malabsorption (HP:0002630) | 2.20556163 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.18936451 |
| 96 | Epidermoid cyst (HP:0200040) | 2.16875497 |
| 97 | Memory impairment (HP:0002354) | 2.16089470 |
| 98 | Generalized aminoaciduria (HP:0002909) | 2.15409651 |
| 99 | Increased CSF protein (HP:0002922) | 2.13609491 |
| 100 | Vertigo (HP:0002321) | 2.13508031 |
| 101 | Vasculitis (HP:0002633) | 2.11915906 |
| 102 | Skin nodule (HP:0200036) | 2.10835629 |
| 103 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.08930383 |
| 104 | Upper motor neuron abnormality (HP:0002127) | 2.06824581 |
| 105 | Personality changes (HP:0000751) | 2.06744324 |
| 106 | Chest pain (HP:0100749) | 2.06515292 |
| 107 | Gastrointestinal infarctions (HP:0005244) | 2.06155848 |
| 108 | Dementia (HP:0000726) | 2.05668746 |
| 109 | Hypercholesterolemia (HP:0003124) | 2.04046266 |
| 110 | Supranuclear gaze palsy (HP:0000605) | 2.03429438 |
| 111 | Leukocytosis (HP:0001974) | 1.98421175 |
| 112 | Global brain atrophy (HP:0002283) | 1.96392453 |
| 113 | Purpura (HP:0000979) | 1.95711824 |
| 114 | Interstitial pulmonary disease (HP:0006530) | 1.95509124 |
| 115 | Recurrent viral infections (HP:0004429) | 1.94639378 |
| 116 | Episodic fever (HP:0001954) | 1.94614069 |
| 117 | Polyneuropathy (HP:0001271) | 1.93604315 |
| 118 | Arterial thrombosis (HP:0004420) | 1.92942904 |
| 119 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.92635483 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92402318 |
| 121 | Agitation (HP:0000713) | 1.92338280 |
| 122 | Cerebral hemorrhage (HP:0001342) | 1.90856283 |
| 123 | Nuclear cataract (HP:0100018) | 1.90565249 |
| 124 | Hypobetalipoproteinemia (HP:0003563) | 1.90336366 |
| 125 | Visual hallucinations (HP:0002367) | 1.88582566 |
| 126 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.88243902 |
| 127 | Pulmonary embolism (HP:0002204) | 1.87728984 |
| 128 | Cardiomegaly (HP:0001640) | 1.87486775 |
| 129 | Polyphagia (HP:0002591) | 1.86861281 |
| 130 | Hyperglycemia (HP:0003074) | 1.86769442 |
| 131 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.85838401 |
| 132 | Increased IgE level (HP:0003212) | 1.85539975 |
| 133 | Elevated alkaline phosphatase (HP:0003155) | 1.82812879 |
| 134 | Papilledema (HP:0001085) | 1.81184109 |
| 135 | Abnormality of the pleura (HP:0002103) | 1.80922310 |
| 136 | Mitral stenosis (HP:0001718) | 1.80700458 |
| 137 | Increased IgM level (HP:0003496) | 1.80491912 |
| 138 | Protuberant abdomen (HP:0001538) | 1.79877675 |
| 139 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.79516196 |
| 140 | Impaired platelet aggregation (HP:0003540) | 1.78969608 |
| 141 | Abnormal platelet function (HP:0011869) | 1.78969608 |
| 142 | Inflammation of the large intestine (HP:0002037) | 1.78427188 |
| 143 | Pathologic fracture (HP:0002756) | 1.78405300 |
| 144 | Hematochezia (HP:0002573) | 1.77760207 |
| 145 | Disinhibition (HP:0000734) | 1.77737613 |
| 146 | Gingivitis (HP:0000230) | 1.76843975 |
| 147 | Epistaxis (HP:0000421) | 1.76334663 |
| 148 | Steatorrhea (HP:0002570) | 1.76266735 |
| 149 | Abnormality of purine metabolism (HP:0004352) | 1.75918562 |
| 150 | Hyperammonemia (HP:0001987) | 1.75684828 |
| 151 | Menorrhagia (HP:0000132) | 1.75356031 |
| 152 | Abnormality of the lumbar spine (HP:0100712) | 1.74942289 |
| 153 | Hyperbilirubinemia (HP:0002904) | 1.72408722 |
| 154 | Colitis (HP:0002583) | 1.71064850 |
| 155 | Nephritis (HP:0000123) | 1.71055422 |
| 156 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.71027940 |
| 157 | Hypokalemic alkalosis (HP:0001949) | 1.70936424 |
| 158 | Irritability (HP:0000737) | 1.70834322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.52133481 |
| 2 | EPHB1 | 3.51733238 |
| 3 | MAPK15 | 3.18776282 |
| 4 | ERN1 | 2.96171641 |
| 5 | MAP3K11 | 2.69948351 |
| 6 | BLK | 2.54754172 |
| 7 | INSRR | 2.50642407 |
| 8 | TGFBR2 | 2.18331878 |
| 9 | IRAK4 | 2.18277609 |
| 10 | STK39 | 2.11737910 |
| 11 | TNK2 | 2.08517339 |
| 12 | KIT | 2.00613902 |
| 13 | MAP4K1 | 1.96071199 |
| 14 | IRAK3 | 1.88421638 |
| 15 | PIK3CG | 1.85972457 |
| 16 | FLT3 | 1.82499662 |
| 17 | TYK2 | 1.80516664 |
| 18 | WNK4 | 1.80253611 |
| 19 | BTK | 1.77414280 |
| 20 | CSF1R | 1.76898333 |
| 21 | TRIB3 | 1.74355906 |
| 22 | TBK1 | 1.72313525 |
| 23 | TAOK1 | 1.70677764 |
| 24 | PRPF4B | 1.67074556 |
| 25 | WNK3 | 1.57263236 |
| 26 | OXSR1 | 1.54167277 |
| 27 | DAPK2 | 1.54046639 |
| 28 | HIPK2 | 1.52414761 |
| 29 | TAOK2 | 1.50787676 |
| 30 | NME2 | 1.47313429 |
| 31 | BCKDK | 1.45079095 |
| 32 | TEC | 1.44279315 |
| 33 | MAPKAPK5 | 1.42469960 |
| 34 | CSK | 1.37112276 |
| 35 | PTK6 | 1.34317992 |
| 36 | BMPR2 | 1.32572806 |
| 37 | SCYL2 | 1.32286790 |
| 38 | PIM2 | 1.31558749 |
| 39 | ITK | 1.31360564 |
| 40 | FGFR4 | 1.29579899 |
| 41 | MET | 1.24710865 |
| 42 | JAK2 | 1.22816608 |
| 43 | EPHA3 | 1.19125111 |
| 44 | FES | 1.17774029 |
| 45 | MAP3K2 | 1.16249205 |
| 46 | CAMKK1 | 1.16087075 |
| 47 | ZAP70 | 1.14787031 |
| 48 | MAP3K13 | 1.10714621 |
| 49 | JAK1 | 1.09102460 |
| 50 | TXK | 1.09036657 |
| 51 | CAMK1D | 1.08555650 |
| 52 | ACVR1B | 1.07993923 |
| 53 | GRK6 | 1.07319736 |
| 54 | MAP2K3 | 1.04618572 |
| 55 | MAP3K1 | 1.04534733 |
| 56 | SIK1 | 1.01954982 |
| 57 | SIK2 | 0.99750844 |
| 58 | TIE1 | 0.97021161 |
| 59 | PASK | 0.94524945 |
| 60 | IRAK1 | 0.94100424 |
| 61 | CAMKK2 | 0.91587633 |
| 62 | SYK | 0.90492547 |
| 63 | LRRK2 | 0.88190121 |
| 64 | NTRK1 | 0.87543018 |
| 65 | RIPK4 | 0.86816432 |
| 66 | MAP2K2 | 0.86520693 |
| 67 | MARK2 | 0.86342269 |
| 68 | ADRBK2 | 0.86011753 |
| 69 | UHMK1 | 0.84473684 |
| 70 | MAP2K4 | 0.84294296 |
| 71 | WNK1 | 0.83895255 |
| 72 | MAP3K14 | 0.82721154 |
| 73 | CAMK1G | 0.81827176 |
| 74 | TESK2 | 0.81804365 |
| 75 | HCK | 0.81677906 |
| 76 | CLK1 | 0.81318988 |
| 77 | MOS | 0.80993805 |
| 78 | LYN | 0.80824844 |
| 79 | CDK19 | 0.79456854 |
| 80 | MAP3K5 | 0.78591041 |
| 81 | PKN2 | 0.78558626 |
| 82 | IKBKE | 0.77970647 |
| 83 | PKN1 | 0.77664438 |
| 84 | JAK3 | 0.77146214 |
| 85 | FGFR2 | 0.76262559 |
| 86 | LCK | 0.75604477 |
| 87 | PDPK1 | 0.73471722 |
| 88 | DYRK3 | 0.72792714 |
| 89 | PRKD1 | 0.69849555 |
| 90 | IKBKB | 0.66811113 |
| 91 | MARK3 | 0.66136596 |
| 92 | RIPK1 | 0.65441687 |
| 93 | FGR | 0.64757881 |
| 94 | GRK7 | 0.64498556 |
| 95 | PRKCH | 0.63910550 |
| 96 | PBK | 0.62792936 |
| 97 | GSK3A | 0.61029222 |
| 98 | MAPK12 | 0.60491605 |
| 99 | MAP3K6 | 0.59283972 |
| 100 | RET | 0.59030876 |
| 101 | KDR | 0.59001572 |
| 102 | CDC42BPA | 0.58780568 |
| 103 | DYRK1B | 0.57443422 |
| 104 | DDR2 | 0.57189389 |
| 105 | PDK1 | 0.57084335 |
| 106 | CSNK1A1L | 0.56741631 |
| 107 | MAPK7 | 0.56703957 |
| 108 | RPS6KL1 | 0.56341265 |
| 109 | RPS6KC1 | 0.56341265 |
| 110 | IRAK2 | 0.55092154 |
| 111 | MATK | 0.54756272 |
| 112 | TRPM7 | 0.53712369 |
| 113 | EGFR | 0.52529499 |
| 114 | RPS6KA6 | 0.52419042 |
| 115 | MAPK4 | 0.51872372 |
| 116 | MAP2K6 | 0.50618596 |
| 117 | PAK6 | 0.50411221 |
| 118 | CSNK1G3 | 0.49642871 |
| 119 | KSR2 | 0.49072705 |
| 120 | PIM1 | 0.47966062 |
| 121 | STK10 | 0.47894325 |
| 122 | PRKAA2 | 0.46561321 |
| 123 | NEK9 | 0.46327863 |
| 124 | PRKCQ | 0.46182346 |
| 125 | ABL2 | 0.45016781 |
| 126 | PINK1 | 0.44732185 |
| 127 | ABL1 | 0.43901389 |
| 128 | STK11 | 0.43758591 |
| 129 | PAK4 | 0.42712406 |
| 130 | TYRO3 | 0.42003186 |
| 131 | MAP3K3 | 0.41690375 |
| 132 | CAMK4 | 0.41588513 |
| 133 | TESK1 | 0.40654370 |
| 134 | FRK | 0.39964722 |
| 135 | CDK6 | 0.39622332 |
| 136 | FYN | 0.39621982 |
| 137 | CSNK1G1 | 0.39609559 |
| 138 | PTK2 | 0.39138877 |
| 139 | RAF1 | 0.38871713 |
| 140 | MAP3K10 | 0.38819005 |
| 141 | NLK | 0.38665256 |
| 142 | CAMK1 | 0.38558242 |
| 143 | PRKCD | 0.38226945 |
| 144 | YES1 | 0.36796534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.55932656 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.29448875 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.09956531 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.66914221 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.54505677 |
| 6 | Lysosome_Homo sapiens_hsa04142 | 2.51323385 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.37640882 |
| 8 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.36301812 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.28223599 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.27658696 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.23569043 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.13697556 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.10134283 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 2.08655582 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.08392556 |
| 16 | Protein export_Homo sapiens_hsa03060 | 2.00729917 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.94865188 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84206384 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.79958145 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.79226020 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.75184526 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64697231 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.62746984 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.61312883 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58673985 |
| 26 | ABC transporters_Homo sapiens_hsa02010 | 1.58095586 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56689606 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.37350385 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.37238325 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.34568045 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.29176560 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.27832418 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.27292511 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.26344903 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.26078056 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24760498 |
| 37 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.23780997 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.22199501 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.21614303 |
| 40 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.20067929 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.20065530 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19603407 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.17793122 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15521366 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14517249 |
| 46 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13548725 |
| 47 | Influenza A_Homo sapiens_hsa05164 | 1.13087366 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.09804161 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.08692633 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.08200903 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07751308 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.05972734 |
| 53 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.05524905 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05077926 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.04922122 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.02610490 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 1.00078104 |
| 58 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98683873 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94667803 |
| 60 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89659208 |
| 61 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88713154 |
| 62 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86671716 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.86128005 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.84553358 |
| 65 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83360978 |
| 66 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.82410094 |
| 67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82041155 |
| 68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81141491 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80167636 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.79934393 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79605708 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.79346134 |
| 73 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78211446 |
| 74 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.78063099 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.77929753 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77444744 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76255853 |
| 78 | Measles_Homo sapiens_hsa05162 | 0.75920515 |
| 79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74723795 |
| 80 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72947429 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72207554 |
| 82 | Shigellosis_Homo sapiens_hsa05131 | 0.71721116 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.69328093 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66092079 |
| 85 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64187909 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.63362671 |
| 87 | Malaria_Homo sapiens_hsa05144 | 0.62811899 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62129639 |
| 89 | Amoebiasis_Homo sapiens_hsa05146 | 0.61775424 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.61525013 |
| 91 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.60701529 |
| 92 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60683359 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60261579 |
| 94 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60189185 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59357197 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.57788037 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57681003 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57136252 |
| 99 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56968926 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54683563 |
| 101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54623518 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54619459 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.54612171 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53535845 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50865336 |
| 106 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.50711718 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50584414 |
| 108 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50430782 |
| 109 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.49167437 |
| 110 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.49004658 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48882610 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47945701 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.47475569 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47405599 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47035693 |
| 116 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46746604 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46687276 |
| 118 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45613777 |
| 119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44752845 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44400818 |
| 121 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42683472 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.40396942 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39837334 |
| 124 | Asthma_Homo sapiens_hsa05310 | 0.39408151 |
| 125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38811024 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.38567337 |
| 127 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.38006065 |
| 128 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.37511072 |
| 129 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36341575 |
| 130 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.36130509 |
| 131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36064666 |
| 132 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35948600 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35646337 |
| 134 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33521378 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.32818007 |
| 136 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32743872 |
| 137 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32381090 |
| 138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.32031495 |
| 139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31969249 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.30864022 |
| 141 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30429558 |
| 142 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29805104 |
| 143 | Bladder cancer_Homo sapiens_hsa05219 | 0.28698517 |
| 144 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28630655 |
| 145 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.28616544 |
| 146 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28304904 |
| 147 | Renin secretion_Homo sapiens_hsa04924 | 0.28200450 |
| 148 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.25152687 |
| 149 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.24695041 |
| 150 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.23696703 |
| 151 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.22690758 |
| 152 | Morphine addiction_Homo sapiens_hsa05032 | 0.22370849 |
| 153 | Long-term potentiation_Homo sapiens_hsa04720 | 0.21835685 |
| 154 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.17580737 |

